Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVYA
1776
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $25.9M | ﹤0.01% |
1,309,731
+14,016
| +1% | +$309K |
|
1777
Algonquin Power & Utilities
AQN
$4.49B
| $25.9M | ﹤0.01% |
1,722,419
+213,259
| +14% | +$3.29M |
|
1778
Brookfield Infrastructure
BIPC
$5.01B
| $25.8M | ﹤0.01% |
645,095
+198,798
| +45% | +$8.7M |
|
1779
Encore Capital Group
ECPG
$2.15B
| $25.7M | ﹤0.01% |
522,163
-11,067
| -2% | -$526K |
|
1780
Bionano Genomics
BNGO
$13.5M
| $25.7M | ﹤0.01% |
7,787
-32
| -0.4% | -$112K |
|
1781
ePlus
PLUS
$2.32B
| $25.7M | ﹤0.01% |
500,278
+4,966
| +1% | +$245K |
|
1782
Malibu Boats
MBUU
$573M
| $25.5M | ﹤0.01% |
365,073
-19,747
| -5% | -$1.48M |
|
1783
Rocket Companies
RKT
$42.6B
| $25.5M | ﹤0.01% |
1,590,421
+31,901
| +2% | +$558K |
|
1784
Bally's
BALY
$660M
| $25.4M | ﹤0.01% |
506,125
-139
| -0% | -$6.78K |
|
1785
Supernus Pharmaceuticals
SUPN
$2.74B
| $25.3M | ﹤0.01% |
949,013
+43,322
| +5% | +$1.16M |
|
|
CIVI
1786
DELISTED
Civitas Resources
CIVI
| $25.3M | ﹤0.01% |
527,861
+99,424
| +23% | +$4.07M |
|
|
XM
1787
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $25.3M | ﹤0.01% |
591,592
+25,788
| +5% | +$1.09M |
|
|
AVNS
1788
DELISTED
Avanos Medical
AVNS
| $25.2M | ﹤0.01% |
807,691
+15,517
| +2% | +$526K |
|
1789
La-Z-Boy
LZB
$1.67B
| $25.2M | ﹤0.01% |
781,569
-901
| -0.1% | -$31.1K |
|
1790
Grocery Outlet
GO
$1.07B
| $25.2M | ﹤0.01% |
1,167,047
+34,138
| +3% | +$982K |
|
1791
GoodRx Holdings
GDRX
$1.27B
| $25.1M | ﹤0.01% |
612,887
+9,316
| +2% | +$338K |
|
|
DCPH
1792
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $25.1M | ﹤0.01% |
738,758
-1,572
| -0.2% | -$50.2K |
|
|
AAMI
1793
Acadian Asset Management
AAMI
$3.31B
| $25.1M | ﹤0.01% |
959,757
-7,271
| -0.8% | -$187K |
|
|
KDMN
1794
DELISTED
Kadmon Holdings, Inc.
KDMN
| $25M | ﹤0.01% |
2,869,385
-77,486
| -3% | -$441K |
|
|
LTC
1795
LTC Properties
LTC
$2.1B
| $24.9M | ﹤0.01% |
785,075
+3,029
| +0.4% | +$108K |
|
|
OPI
1796
DELISTED
Office Properties Income Trust
OPI
| $24.9M | ﹤0.01% |
981,391
-11,280
| -1% | -$307K |
|
1797
The Greenbrier Companies
GBX
$1.42B
| $24.8M | ﹤0.01% |
577,822
+21,416
| +4% | +$923K |
|
1798
Allegro MicroSystems
ALGM
$8.22B
| $24.8M | ﹤0.01% |
776,831
+121,101
| +18% | +$3.57M |
|
1799
National Beverage
FIZZ
$2.93B
| $24.8M | ﹤0.01% |
472,931
+11,510
| +2% | +$536K |
|
1800
BancFirst
BANF
$3.89B
| $24.8M | ﹤0.01% |
412,800
-6,565
| -2% | -$375K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.